Key Factors for COVID-19 Containment Identified

The impact of natural and vaccine-induced immunity is the key factors in shaping the future trajectory of the global coronavirus pandemic, suggested new research.

In particular, a vaccine capable of eliciting a strong immune response could substantially reduce the future burden of infection, according to a study recently published in the journal Science.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

‘COVID-19: The new model indicates that if vaccine refusal is high and correlated with increased transmission and riskier behavior such as refusing to wear a mask, then the necessary vaccination rate needed to reach herd immunity could be much higher.’

"The current study builds on previous research which reported that local variations in climate are not likely to dominate the first wave of the Covid-19 pandemic," said study authors from McGill University in Canada.

In the most recent paper, the researchers used a simple model to project the future incidence of Covid-19 cases -- and the degree of immunity in the human population -- under a range of assumptions related to how likely individuals are to transmit the virus in different contexts.

For example, the model allows for different durations of immunity after infection, as well as different extents of protection from reinfection.

COVID-19 In Andhra: 2901 More Cases, Tally Reaches 8.1 Lakh
Andhra Pradesh has registered 2,901 new COVID positive cases, increasing the state's tally to 8.1 lakh, even as 4,352 more patients recovered from the virus to outnumber infections.

The researchers posted online an interactive version of model's predictions under these different sets of assumptions.

As expected, the model found that the initial pandemic peak is largely independent of immunity because most people are susceptible.

COVID-19 Gives New Challenges for Patients With Gaucher
The COVID-19 pandemic has ushered in a new normal the world over and has thrown up challenges of varying magnitude, especially for the patients with rare disorders.

However, a substantial range of epidemic patterns are possible as SARS-CoV-2 infection -- and thus immunity -- increases in the population.

"If immune responses are only weak, or transiently protective against reinfection, for example, then larger and more frequent outbreaks can be expected in the medium term," said co-author Andrea Graham from Princeton University.

COVID-19 In India: Numbers Touching 80L But Daily Spike Dips
With a fresh spike of 43,893 coronavirus infections and 508 deaths in 24 hours, India's COVID-19 tally stood at 79,90,322.

The nature of the immune responses also can affect clinical outcomes and the burden of severe cases requiring hospitalization, the researchers found.

Importantly, the study found that in all scenarios a vaccine capable of eliciting a strong immune response could substantially reduce future caseloads.

Even a vaccine that only offers partial protection against secondary transmission could generate major benefits if widely deployed, the researchers reported.

The study authors also explored the effect of "vaccine hesitancy" on future infection dynamics.

Their model found that people who decline to partake in pharmaceutical and non-pharmaceutical measures to contain the coronavirus could nonetheless slow containment of the virus even if a vaccine is available.

Source-IANS